[1] |
GUO L N,XIAO M,CAO B,et al.Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing,China[J]. Future Microbiol,2017,12:1075-1086.
|
[2] |
ULU KILIC A,ALP E,CEVAHIR F,et al.Epidemiology and cost implications of candidemia,a 6-year analysis from a developing country[J]. Mycoses,2017,60(3):198-203.
|
[3] |
RUIZ-RUIGÓMEZ M,DUEÑAS C,HERNANDEZ C,et al. Clinical predictors of candidemia in medical non-neutropenic,non-ICU patients. The CaMed score[J]. Int J Clin Pract,2018,72(12):e13275.
|
[4] |
GONÇALVES B,FERREIRA C,ALVES C T,et al. Vulvovaginal candidiasis:epidemiology,microbiology and risk factors[J]. Crit Rev Microbiol,2016,42(6):905-927.
|
[5] |
DATTA P,KAUR M,GOMBAR S,et al.Epidemiology and antifungal susceptibility of Candida species isolated from urinary tract infections:a study from an intensive care unit of a tertiary care hospital[J]. Indian J Crit Care Med,2018,22(1):56-57.
|
[6] |
FENG W,YANG J,YANG L,et al.Research of Mrr1,Cap1 and MDR1 in Candida albicans resistant to azole medications[J]. Exp Ther Med,2018,15(2):1217-1224.
|
[7] |
CHIU P,LEUNG L T,KO B C.Pseudolaric acids:isolation,bioactivity and synthetic studies[J]. Nat Prod Rep,2010,27(7):1066-1083.
|
[8] |
YU J,WANG Z,REN P,et al.Pseudolaric acid B inhibits the secretion of hepatitis B virus[J]. Oncol Rep,2017,37(1):519-525.
|
[9] |
SUN Q,LI Y.The inhibitory effect of pseudolaric acid B on gastric cancer and multidrug resistance via Cox-2/PKC-α/P-gp pathway[J]. PLoS One,2014 ,9(9):e107830.
|
[10] |
汪承英,马超瑜,尹笋君,等. 三种生物碱与氟康唑体外协同抗白色念珠菌活性研究[J]. 解放军药学学报,2015,31(4):310-312.
|
[11] |
Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeast[S]. M27-A3,CLSI,2008.
|
[12] |
LIU S,HOU Y,CHEN X,et al.Combination of fluconazole with non-antifungal agents:a promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery[J]. Int J Antimicrob Agents,2014,43(5):395-402.
|
[13] |
XU Y,QUAN H,WANG Y,et al.Requirement for ergosterol in berberine tolerance underlies synergism of fluconazole and berberine against fluconazole-resistant Candida albicans isolates[J]. Front Cell Infect Microbiol,2017,7:491.
|
[14] |
YAN Z,HUA H,XU Y,et al.Potent antifungal activity of pure compounds from traditional Chinese medicine extracts against six oral Candida species and the synergy with fluconazole against azole-resistant Candida albicans[J]. Evid Based Complement Alternat Med,2012,2012:106583.
|
[15] |
SHAO J,SHI G,WANG T,et al.Antiproliferation of berberine in combination with fluconazole from the perspectives of reactive oxygen species,ergosterol and drug efflux in a fluconazole-resistant Candida tropicalis isolate[J]. Front Microbiol,2016,7:1516.
|